Daniel Bertholet
Investing Profile
Sweet spot: $1.5M
Range: $100K–$5M
4See Ventures thesis
COMPANIES DISTALMOTION Distal Motion brings to market the Dexter – medical robotics made simple with seamless integration into existing laparoscopic procedures. WEB SITE HAYA THERAPEUTICS Haya Therapeutics is developing long non-coding RNAs to target fibrosis in the heart. This unique approach is being developed to treat heart failure and also offers potential to target fibrosis in other organs WEB SITE TRANSMUTEX Based on a concept validated at CERN, Transmutex aims to couple a particle accelerator to a thorium fission reactor with the goal of efficiently reducing the stockpile of existing n
Sector and stage focus
- Seed: Medical Devices, Pharmaceuticals, BioTech, Health IT, Digital Health, Health & Hospital Services
- Series B: BioTech, Medical Devices, Pharmaceuticals, Health & Hospital Services, Digital Health, Health IT
- Series A: Medical Devices, Pharmaceuticals, BioTech, Health IT, Health & Hospital Services, Digital Health
Is Daniel Bertholet a fit for your round?
Upload your pitch deck and see whether Daniel Bertholet appears in your top 20 matches.
Find investors for your deck